Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.12
+0.02 (0.25%)
Oct 28, 2026, 4:00 PM EDT - Market closed

Grifols Revenue

Grifols had revenue of 1.87B EUR in the quarter ending June 30, 2026, a decrease of -0.91%. This brings the company's total for the last twelve months to 7.42B, down -0.33% year-over-year. In the year 2025, Grifols had annual revenue of 7.52B with 4.33% growth.

Revenue (ttm)
7.42B EUR
Revenue Growth
-0.33%
P/S Ratio
0.84
Revenue / Employee
293,938 EUR
Employees
25,247
Market Cap
7.15B USD

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Biopharma 6.49B 86.2%
  • Diagnostic 640.00M 8.5%
  • Others 243.00M 3.2%
  • Bio Supplies 154.00M 2.0%

By Geography

Chart
  • USA and Canada 4.25B 56.5%
  • Rest of World 1.66B 22.0%
  • Rest of European Union 1.20B 15.9%
  • Spain 418.00M 5.6%
Fiscal year ended Dec 31, 2025 See the full Grifols breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.52B312.00M4.33%
Dec 31, 20247.21B620.02M9.41%
Dec 31, 20236.59B528.01M8.71%
Dec 31, 20226.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B611.97M13.64%
Dec 31, 20184.49B168.65M3.91%
Dec 31, 20174.32B268.24M6.62%
Dec 31, 20164.05B115.27M2.93%
Dec 31, 20153.93B579.18M17.26%
Dec 31, 20143.36B613.65M22.38%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B825.33M45.96%
Dec 31, 20111.80B804.88M81.24%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pfizer63.70B
AstraZeneca61.37B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
GSK plc44.05B
Amgen38.10B
Gilead Sciences30.46B
Revenue Rankings